EYE
Overvalued by 4.8% based on the discounted cash flow analysis.
Market cap | $1.26 Billion |
---|---|
Enterprise Value | $1.57 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-0.97 |
Beta | 1.68 |
Outstanding Shares | 78,560,994 |
Avg 30 Day Volume | 1,336,853 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -17.35 |
---|---|
PEG | 48.14 |
Price to Sales | 0.61 |
Price to Book Ratio | 1.58 |
Enterprise Value to Revenue | 0.74 |
Enterprise Value to EBIT | 58.69 |
Enterprise Value to Net Income | -22 |
Total Debt to Enterprise | 0.29 |
Debt to Equity | 0.55 |
No data
No data